Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

Augmented control of ecological and evolutionary success in bacterial populations

Objetivo

Escherichia coli is a bacterial model organism with broad applications in molecular genetics and is clinically the most significant cause of bacterial infections. Domesticated E. coli have been the subject of fundamental research on bacterial evolution and genetics for decades, yet we have limited understanding of the mechanisms regulating natural E. coli populations that near-universally colonise the human gut. Evidence points to the existence of strong equilibria of lineage prevalence and synchronised appearance of novel genotypes across host populations, yet how such equilibria emerge and are maintained remains unclear. ACES aims to fill this knowledge gap through a combination of innovative sampling frames and in vivo experiments with the latest long-read sequencing and analytical techniques, including targeted PacBio shotgun metagenomics and simulation-based modelling. These technological advances provide an opportunity to obtain a refined characterisation of all genomic variation occurring in an E. coli population, including gene content, capsular antigens, plasmidome and phageome. The main hypothesis of ACES is that key accessory genomic elements augment the genetic capabilities encoded by the core genome and together control the ecological and evolutionary success of individual genotypes over time. ACES will develop models to assess whether observed population equilibria arise as a consequence of the success strategies driven by the accessory elements. The knowledge generated by ACES will have broad implications for understanding bacterial ecology and evolution, and our approach will pave the way to similar studies outside of bacterial model organisms in the future. ACES will also facilitate future prediction of the consequences of population interventions, such as novel antibiotics, probiotics and vaccines, informing the development of new means to alleviate the ongoing global antibiotic resistance crisis.

Ámbito científico (EuroSciVoc)

Palabras clave

Programa(s)

Tema(s)

Régimen de financiación

HORIZON-ERC - HORIZON ERC Grants

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) ERC-2025-ADG

Ver todos los proyectos financiados en el marco de esta convocatoria

Institución de acogida

UNIVERSITETET I OSLO
Aportación neta de la UEn
€ 1 944 700,00
Coste total
Sin datos

Beneficiarios (3)